Join
Live feed
·
NEWSReleasevia Quantisnow
Centogene N.V. logo

Centogene shares are trading higher after the company signed a Memorandum of Understanding with C-Path for collaboration in lysosomal disease research and drug development.

ByQuantisnow·Wall Street's wire, on your screen.
CNTG· Centogene N.V.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CNTG (Centogene N.V.) and more on Quantisnow.